EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C11H13BrN3O5P.HCl |
| Net Charge | 0 |
| Average Mass | 414.580 |
| Monoisotopic Mass | 412.95430 |
| SMILES | C[C@@H](NCc1cc(Br)cc2nc(=O)c(=O)nc12)P(=O)(O)O.Cl |
| InChI | InChI=1S/C11H13BrN3O5P.ClH/c1-5(21(18,19)20)13-4-6-2-7(12)3-8-9(6)15-11(17)10(16)14-8;/h2-3,5,13H,4H2,1H3,(H,14,16)(H,15,17)(H2,18,19,20);1H/t5-;/m0./s1 |
| InChIKey | MZQQZBPMRPDKTB-JEDNCBNOSA-N |
| Roles Classification |
|---|
| Biological Role: | NMDA receptor antagonist Any substance that inhibits the action of N-methyl-D-aspartate (NMDA) receptors. They tend to induce a state known as dissociative anesthesia, marked by catalepsy, amnesia, and analgesia, while side effects can include hallucinations, nightmares, and confusion. Due to their psychotomimetic effects, many NMDA receptor antagonists are used as recreational drugs. |
| Applications: | anticonvulsant A drug used to prevent seizures or reduce their severity. prodrug A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| CGP 78608 hydrochloride (CHEBI:64065) has role anticonvulsant (CHEBI:35623) |
| CGP 78608 hydrochloride (CHEBI:64065) has role NMDA receptor antagonist (CHEBI:60643) |
| CGP 78608 hydrochloride (CHEBI:64065) has role prodrug (CHEBI:50266) |
| CGP 78608 hydrochloride (CHEBI:64065) is a hydrochloride (CHEBI:36807) |
| CGP 78608 hydrochloride (CHEBI:64065) is conjugate base of CGP 78608(1+) (CHEBI:64066) |
| Incoming Relation(s) |
| CGP 78608(1+) (CHEBI:64066) is conjugate acid of CGP 78608 hydrochloride (CHEBI:64065) |
| IUPAC Names |
|---|
| (1S)-N-[(7-bromo-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)methyl]-1-phosphonoethanaminium chloride |
| [(1S)-1-{[(7-bromo-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)methyl]amino}ethyl]phosphonic acid hydrochloride |